0000899243-18-031272.txt : 20181217 0000899243-18-031272.hdr.sgml : 20181217 20181217211200 ACCESSION NUMBER: 0000899243-18-031272 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180706 FILED AS OF DATE: 20181217 DATE AS OF CHANGE: 20181217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schor Chen CENTRAL INDEX KEY: 0001340875 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38359 FILM NUMBER: 181239279 MAIL ADDRESS: STREET 1: PREDIX PHARMACEUTICALS HOLDINGS, INC. STREET 2: 4 MAGUIRE ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: resTORbio, Inc. CENTRAL INDEX KEY: 0001720580 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 813305277 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 BOYLSTON STREET STREET 2: 12TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-482-2333 MAIL ADDRESS: STREET 1: 500 BOYLSTON STREET STREET 2: 12TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-07-06 0 0001720580 resTORbio, Inc. TORC 0001340875 Schor Chen C/O RESTORBIO, INC. 500 BOYLSTON STREET, 12TH FLOOR BOSTON MA 02116 1 1 0 0 See Remarks Common Stock 2018-07-06 5 G 0 E 943000 0.00 D 949363 D Common Stock 2018-10-15 5 G 0 E 593363 0.00 D 356000 D Common Stock 2018-10-15 5 G 0 E 25000 0.00 D 331000 D Common Stock 2018-10-15 5 G 0 E 643000 0.00 D 943000 I See Footnote Common Stock 2018-10-15 5 G 0 E 25000 0.00 D 943000 I See Footnote Common Stock 2018-11-05 5 G 0 E 6000 0.00 D 325000 D Common Stock 1567363 I See Footnote On July 6, 2018, the reporting person transferred 943,000 shares of common stock to his spouse. The reporting person disclaims Section 16 beneficial ownership of these shares except to the extent, if any, of the reporting person's pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose. Following this transfer, the reporting person directly held 949,363 shares and his spouse directly held 943,000 shares. On October 15, 2018, the reporting person transferred 593,363 shares of common stock to an irrevocable family trust having an independent trustee (the "Schor Irrevocable Trust"). The reporting person disclaims Section 16 beneficial ownership of these shares except to the extent, if any, of the reporting person's pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose. On October 15, 2018, the reporting person transferred 25,000 shares of common stock to a revocable family trust of which the reporting person is the trustee (the "Schor Revocable Trust"). The reporting person disclaims Section 16 beneficial ownership of such shares except to the extent, if any, of the reporting person's pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose. On the same date, the reporting person transferred 325,000 shares to a grantor retained annuity trust, which shares are included in the reporting person's direct ownership. On October 15, 2018, the reporting person's spouse transferred 643,000 shares of common stock to an irrevocable family trust having an independent trustee (the "Spousal Irrevocable Trust"). The reporting person disclaims Section 16 beneficial ownership of these shares except to the extent, if any, of the reporting person's pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose. On October 15, 2018, the reporting person's spouse transferred 25,000 shares of common stock to a revocable trust of which the spouse is the trustee (the "Spousal Revocable Trust"). On the same date, the reporting person's spouse transferred 275,000 shares to a grantor retained annuity trust (the "Spousal GRAT"). The reporting person disclaims Section 16 beneficial ownership of all such shares except to the extent, if any, of the reporting person's pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose. On November 5, 2018, the reporting person transferred 6,000 shares of common stock to the Schor Irrevocable Trust. The reporting person disclaims Section 16 beneficial ownership of these shares except to the extent, if any, of the reporting person's pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose. Represents 599,363 shares held directly by the Schor Irrevocable Trust, 25,000 shares held by the Schor Revocable Trust, 643,000 shares held directly by the Spousal Irrevocable Trust, 25,000 shares held directly by the Spousal Revocable Trust and 275,000 shares held directly by the Spousal GRAT. President and Chief Executive Officer /s/ Chen Schor 2018-12-17